GSK (LON:GSK) Earns Buy Rating from Shore Capital
GSK (LON:GSK – Get Rating)‘s stock had its “buy” rating restated by equities research analysts at Shore Capital in a note issued to investors on Friday, Digital Look reports. GSK has been the subject of several other reports. Berenberg Bank restated a “buy” rating and set a GBX 1,730 ($21.65) price target on shares of … [Read more…]